| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1084512819 |
| P356 | DOI | 10.1186/S12951-017-0259-4 |
| P932 | PMC publication ID | 5379608 |
| P698 | PubMed publication ID | 28376812 |
| P50 | author | Luiz O Ladeira | Q64355225 |
| Erna G. Kroon | Q40456670 | ||
| Milene A Rachid | Q56378259 | ||
| Ado Jorio | Q57321745 | ||
| Alice F Versiani | Q58880559 | ||
| P2093 | author name string | Ruiz G Astigarraga | |
| Ana Paula M Barboza | |||
| Edel F Barbosa-Stancioli | |||
| Daniele G Souza | |||
| Eliseu S O Rocha | |||
| Flávio G Da Fonseca | |||
| P2860 | cites work | The global distribution and burden of dengue | Q24628768 |
| Helical microtubules of graphitic carbon | Q25939001 | ||
| Multi-walled carbon nanotubes increase antibody-producing B cells in mice immunized with a tetravalent vaccine candidate for dengue virus | Q26700122 | ||
| Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment | Q26746185 | ||
| Insertion of short amino-functionalized single-walled carbon nanotubes into phospholipid bilayer occurs by passive diffusion | Q27334273 | ||
| Development of a recombinant tetravalent dengue virus vaccine: Immunogenicity and efficacy studies in mice and monkeys | Q27491049 | ||
| Dengue: a continuing global threat | Q28298464 | ||
| Single-walled carbon nanotubes deliver peptide antigen into dendritic cells and enhance IgG responses to tumor-associated antigens | Q28390624 | ||
| Carbon nanotubes as vaccine scaffolds | Q28392532 | ||
| Effects of multiwalled carbon nanotubes and triclocarban on several eukaryotic cell lines: elucidating cytotoxicity, endocrine disruption, and reactive oxygen species generation | Q28392927 | ||
| Cellular uptake of functionalized carbon nanotubes is independent of functional group and cell type | Q81697625 | ||
| Synthesis, structural characterization, and immunological properties of carbon nanotubes functionalized with peptides | Q33187268 | ||
| Elucidating the role of T cells in protection against and pathogenesis of dengue virus infections | Q33959381 | ||
| Evaluation of the traditional and revised WHO classifications of Dengue disease severity | Q34075766 | ||
| Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease | Q34487028 | ||
| Simultaneous blocking of human Toll-like receptors 2 and 4 suppresses myeloid dendritic cell activation induced by Mycobacterium bovis bacillus Calmette-Guérin peptidoglycan | Q35164750 | ||
| Defect characterization in graphene and carbon nanotubes using Raman spectroscopy | Q37805884 | ||
| Immune response to dengue virus and prospects for a vaccine | Q37827145 | ||
| Liposome delivery of Chlamydia muridarum major outer membrane protein primes a Th1 response that protects against genital chlamydial infection in a mouse model | Q37856989 | ||
| Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms | Q37901360 | ||
| Making carbon nanotubes biocompatible and biodegradable | Q37903284 | ||
| The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease | Q37903445 | ||
| Advances in use of functionalized carbon nanotubes for drug design and discovery | Q38040429 | ||
| Identifying protective dengue vaccines: guide to mastering an empirical process | Q38125045 | ||
| Revisiting dengue virus-host cell interaction: new insights into molecular and cellular virology | Q38174301 | ||
| A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available | Q38184218 | ||
| Using Plasmids as DNA Vaccines for Infectious Diseases | Q38535937 | ||
| Functionalized carbon nanotubes as immunomodulator systems | Q39178999 | ||
| Immunization of rhesus monkeys with a recombinant of modified vaccinia virus Ankara expressing a truncated envelope glycoprotein of dengue type 2 virus induced resistance to dengue type 2 virus challenge | Q39243877 | ||
| Recombinant envelope protein-based enzyme immunoassay for IgG antibodies is comparable to neutralization tests for epidemiological studies of dengue infection | Q39403147 | ||
| Carbon nanotubes conjugated to tumor lysate protein enhance the efficacy of an antitumor immunotherapy | Q39948212 | ||
| A novel dengue virus serotype-2 nanovaccine induces robust humoral and cell-mediated immunity in mice | Q40168564 | ||
| Immunogenicity of a recombinant envelope domain III protein of dengue virus type-4 with various adjuvants in mice | Q40413896 | ||
| Carbon nanotubes as intracellular protein transporters: generality and biological functionality | Q40429515 | ||
| Escherichia coli expressing recombinant antigen and listeriolysin O stimulate class I-restricted CD8+ T cells following uptake by human APC. | Q40597271 | ||
| A plaque reduction test for dengue virus neutralizing antibodies | Q40952803 | ||
| Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6'-dibehenate)-a novel adjuvant inducing both strong CMI and antibody responses | Q41626628 | ||
| Immunization with peptide-functionalized carbon nanotubes enhances virus-specific neutralizing antibody responses | Q45710607 | ||
| Novel generation mycobacterial adjuvant based on liposome-encapsulated monomycoloyl glycerol from Mycobacterium bovis bacillus Calmette-Guérin. | Q45924628 | ||
| Immunological profile of a Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium berghei mouse model | Q46140366 | ||
| Delivering the vaccination mail | Q51808705 | ||
| Evaluation of humoral and cellular immune response of BALB/c mice immunized with a recombinant fragment of MSP1a from Anaplasma marginale using carbon nanotubes as a carrier molecule. | Q53063435 | ||
| Oxidized multiwalled carbon nanotubes as antigen delivery system to promote superior CD8(+) T cell response and protection against cancer | Q57162793 | ||
| Chemical vapor deposition of multi-walled carbon nanotubes from nickel/yttria-stabilized zirconia catalysts | Q57962873 | ||
| Ex vivo impact of functionalized carbon nanotubes on human immune cells | Q58294585 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Dengue virus | Q476209 |
| carbon nanotube | Q1778729 | ||
| P304 | page(s) | 26 | |
| P577 | publication date | 2017-04-04 | |
| P1433 | published in | Journal of Nanobiotechnology | Q15752156 |
| P1476 | title | Multi-walled carbon nanotubes functionalized with recombinant Dengue virus 3 envelope proteins induce significant and specific immune responses in mice | |
| P478 | volume | 15 |
| Q54989481 | A carbon nanotube-gemcitabine-lentinan three-component composite for chemo-photothermal synergistic therapy of cancer. |
| Q59349930 | Bionanotechnology for vaccine design |
| Q97521483 | Challenges in Dengue Vaccines Development: Pre-existing Infections and Cross-Reactivity |
| Q90226249 | Derivatized Carbon Nanotubes for Gene Therapy in Mammalian and Plant Cells |
| Q40038715 | Development of Peptide Vaccines in Dengue. |
| Q91650081 | Long-Term Protection Elicited by a DNA Vaccine Candidate Expressing the prM-E Antigen of Dengue Virus Serotype 3 in Mice |
| Q97539391 | Nanosensors based on LSPR are able to serologically differentiate dengue from Zika infections |
| Q98197151 | Nanotechnology-based antiviral therapeutics |
| Q57483923 | Raman spectroscopy-based identification of toxoid vaccine products |
| Q56960671 | Recent Developments in Recombinant Protein-Based Dengue Vaccines |
| Q64074574 | Synthesis of Gold Nanoparticles Decorated with Multiwalled Carbon Nanotubes (Au-MWCNTs) via Cysteaminium Chloride Functionalization |
Search more.